Dennis Benjamin

Dennis has +25 years of experience in drug discovery, including the position of SVP of research at SeaGen, where he was a key architect of the company’s ADC technology platform. Over his career, Dennis has led teams that have discovered over 20 molecules which have entered clinical trials (including ADCs, antibodies and small molecules) and contributed to four drug approvals.